The company will select more than 90 clinical sites in the USA, Finland, Poland and Spain for the study. Children will be given two doses of 10 micrograms each.
New Delhi. The corona vaccine will now also be tested on children under 12 years of age. Pfizer Inc. Says he will start testing the Covid-19 vaccine in a large group of children after setting a low dose in the first phase of the trial.
Read more: Gujarat: Action against traders who could not get covid vaccine in Surat, 748 shops closed
Choose small doses
According to the company, it will select more than 90 clinical sites in the US, Finland, Poland and Spain for the study. It will register 4,500 children here. Pfizer said it would select small doses of the vaccine in the first phase of the hearing. Covid-19 vaccination tests have been introduced in a large group of children under 12 years of age.
Expect final results by September
According to a Pfizer spokesperson, the company expects data on children between the ages of 5 and 11 to arrive in September. Regulators will be asked for immediate use of the vaccine later this month. The data for children aged 2 to 5 will come soon, the spokesman said. Pfizer expects data to also be available for children aged six months to two months in October or November.
The selection of children aged 5 to 11 for the vaccination trial will begin this week, according to the company. These children will be given two doses of 10 micrograms each. This dose is believed to be one-third of the amount of vaccine given to adolescents and adults. After a few weeks, the vaccine trial will begin on babies older than six months. They will be vaccinated with three micrograms.
Read more: A huge fire broke out at the cash counter of Mata Vaishnav Devi temple in about 1 hour
Many companies are doing tests
In addition to Pfizer, Moderna is also testing a 12-17 year old vaccine. Its results are also coming out soon. Last month, AstraZeneca launched a study in the UK on children aged 6 to 17. At the same time, Johnson and Johnson have also begun studying children. At the same time, China’s Sinovak has said its vaccine is effective on children up to three years old.